Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis C virus coinfection: results of a randomized clinical study
about
Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virusChallenges in the treatment of HIV and HCV coinfection.Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV.Pharmacokinetics of ribavirin in patients with hepatitis C virus.High levels of zidovudine (AZT) and its intracellular phosphate metabolites in AZT- and AZT-lamivudine-treated newborns of human immunodeficiency virus-infected mothersNanomedicines in the treatment of patients with hepatitis C co-infected with HIV--focus on pegylated interferon-alpha.Cytokine and sex hormone effects on zidovudine- and lamivudine-triphosphate concentrations in vitro.Drug interactions in the management of HIV infection: an update.Associated factors of drug-drug interactions of highly active antiretroviral therapy: report from a referral center.Evidence and possible consequences of the phosphorylation of nucleoside reverse transcriptase inhibitors in human red blood cells.Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team.Absence of clinically relevant pharmacokinetic interaction between ribavirin and tenofovir in healthy subjects.
P2860
Q24240929-12C9A231-D9CB-4B67-882F-B7DD0D1AABA0Q30389282-3D233E63-60E7-49C6-A969-2D0E58B1F138Q35233168-069B3517-CAE7-4A8E-9A4C-B48FC0CF15D2Q35648745-ED0E2CF2-19C3-4482-BD77-154B051CBB06Q36744874-A4035266-2A9B-4484-A27D-06FB9B3511B1Q36920320-BD516827-3596-421A-81D3-7E1007494884Q36951689-1FAB9F76-6278-41B9-9CF0-FF450D604CBCQ37000733-8B8481E6-F6DF-494C-B910-5DF2CC49063BQ41564295-12AC229A-3FBB-46F4-8D53-D57FA73D3B6FQ42747686-B3020359-0CA9-4C3E-8005-3787D101DD0FQ43037722-E37C23C5-AA31-4B24-B9FF-27A29F19FEC6Q43038391-206760E0-ED31-484B-B5CB-63346BDE26DBQ50576419-2F80AD0B-DF13-4B8E-9E25-CFB9A2CA42E4
P2860
Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis C virus coinfection: results of a randomized clinical study
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Effect of Ribavirin on Intrace ...... of a Randomized Clinical Study
@nl
Effect of ribavirin on intrace ...... of a randomized clinical study
@ast
Effect of ribavirin on intrace ...... of a randomized clinical study
@en
type
label
Effect of Ribavirin on Intrace ...... of a Randomized Clinical Study
@nl
Effect of ribavirin on intrace ...... of a randomized clinical study
@ast
Effect of ribavirin on intrace ...... of a randomized clinical study
@en
prefLabel
Effect of Ribavirin on Intrace ...... of a Randomized Clinical Study
@nl
Effect of ribavirin on intrace ...... of a randomized clinical study
@ast
Effect of ribavirin on intrace ...... of a randomized clinical study
@en
P2093
P2860
P1476
Effect of ribavirin on intrace ...... of a randomized clinical study
@en
P2093
D Dieterich
F J Torriani
M J Borucki
M Rodriguez-Torres
M Sulkowski
P G Hoggard
P2860
P304
P356
10.1128/AAC.49.10.3997-4008.2005
P407
P577
2005-10-01T00:00:00Z